Gwen A Melincoff Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gwen A Melincoff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gwen A Melincoff. Gwen A Melincoff is a Director in Protalix BioTherapeutics, Inc. ($PLX) and a Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and a Director in Tobira Therapeutics, Inc. ($TBRA) and a Director in SOLENO THERAPEUTICS INC ($SLNO).
Address: C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD SUITE 300 SOUTH SAN FRANCISCO 94080 CA
Companies in which Gwen A Melincoff is an Insider
COLLEGIUM PHARMACEUTICAL, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gwen A Melincoff: Director
Holdings: 11,007 shares
Current Value: $169,068
Latest Transaction: May 22 2020
$COLL Market Capitalization: $351.67M
$COLL Previous Close: $15.36
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Protalix BioTherapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Gwen A Melincoff: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 22 2020
$PLX Market Capitalization: $78.10M
$PLX Previous Close: $0.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SOLENO THERAPEUTICS INC
Industry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of Gwen A Melincoff: Director
Holdings: 10,000 shares
Current Value: $8,500
Latest Transaction: Jan 12 2021
$SLNO Market Capitalization: $13.22M
$SLNO Previous Close: $0.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tobira Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gwen A Melincoff: Director
Holdings: 0 shares
Latest Transaction: Nov 03 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gwen A Melincoff
Sentiment: All, COLL, PLX, SLNO, TBRA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2021 | SLNO | SOLENO THERAPEUTIC ... | Melincoff Gwen A | Director | Option Exercise | A | 2.24 | 40,000 | 89,600 | 81,887 | |
| May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Option Exercise | A | 22.05 | 8,095 | 178,495 | 8,095 | |
| May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Melincoff Gwen A | Director | Grant | A | 0.00 | 4,047 | 0 | 11,007 | 7 K to 11 K (+58.15 %) |
| May 20 2020 | SLNO | SOLENO THERAPEUTIC ... | Melincoff Gwen A | Director | Option Exercise | A | 3.41 | 9,530 | 32,497 | 9,530 | |
| Jan 22 2020 | PLX | Protalix BioTherap ... | Melincoff Gwen A | Director | Option Exercise | A | 3.55 | 40,000 | 142,000 | 40,000 | |
| Nov 20 2019 | SLNO | SOLENO THERAPEUTIC ... | Melincoff Gwen A | Director | Buy | P | 1.54 | 10,000 | 15,364 | 10,000 | 0 to 10 K |
| Jun 12 2019 | SLNO | SOLENO THERAPEUTIC ... | Melincoff Gwen A | Director | Option Exercise | A | 2.50 | 13,000 | 32,500 | 13,000 |